MORGAN STANLEY

Holdings History for Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

Symbol: AMLX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$28,506,673	2,359,824	+409,523	+21%	$12.08	Q4 2025
30 Sep 2025	0%	+0%	$26,504,591	1,950,301	+1,463,408	+301%	$13.59	Q3 2025
30 Jun 2025	0%	+0%	$3,120,984	486,893	+12,475	+2.6%	$6.41	Q2 2025
31 Mar 2025	0%	+0%	$1,679,440	474,418	+10,198		$3.54	Q1 2025
31 Dec 2024	0%	-0%	$1,754,752	464,220	-14,045		$3.78	Q4 2024
30 Sep 2024	0%	-0%	$1,549,578	478,265	-446,194		$3.24	Q3 2024
30 Jun 2024	0%	-0%	$1,756,473	924,459	-1,146,194		$1.90	Q2 2024
31 Mar 2024	0%	-0%	$5,880,656	2,070,653	-759,590	-27%	$2.84	Q1 2024
31 Dec 2023	0%	+0%	$41,661,177	2,830,243	+1,878,124	+197%	$14.72	Q4 2023
30 Sep 2023	0%	-0%	$17,433,297	952,119	-99,727	-9.5%	$18.31	Q3 2023
30 Jun 2023	0%	+0%	$22,688,319	1,051,846	+149,299	+17%	$21.57	Q2 2023
31 Mar 2023	0%	+0%	$26,480,729	902,547	+418,078	+86%	$29.34	Q1 2023
31 Dec 2022	0%	+0%	$17,901,129	484,469	+215,421	+80%	$36.95	Q4 2022
30 Sep 2022		0%	$1,000	20	0		$50.00 ^*	Q3 2022
30 Sep 2022	0%	+0%	$7,574,000	269,048	+225,977	+525%	$28.15	Q3 2022
30 Jun 2022	0%	+0%	$829,000	43,071	+726	+1.7%	$19.25	Q2 2022
31 Mar 2022	0%	+0%	$544,000	42,345	+42,345	NEW	$12.85	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.